2009
DOI: 10.1016/j.bmcl.2009.07.083
|View full text |Cite
|
Sign up to set email alerts
|

Dihydropyrazolopyrimidines containing benzimidazoles as KV1.5 potassium channel antagonists

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
21
0
1

Year Published

2010
2010
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 44 publications
(23 citation statements)
references
References 10 publications
1
21
0
1
Order By: Relevance
“…17 Starting from substituted acetyl chlorides 4a-d, conversion to the corresponding acylated Meldrum's acids 5a-d proceeded in excellent yield (Scheme 2) using methodology which has recently been reported. 18 Further collapse of this system with t-butanol was very efficient, giving esters 6a-d. In order to demonstrate that such intermediates could be used to perform the desired ring closing aldol reaction, one of them (6a) was hydrolysed to acid 7 and converted to malonamide 8 by DCC coupling with oxazolidine 1.…”
mentioning
confidence: 99%
“…17 Starting from substituted acetyl chlorides 4a-d, conversion to the corresponding acylated Meldrum's acids 5a-d proceeded in excellent yield (Scheme 2) using methodology which has recently been reported. 18 Further collapse of this system with t-butanol was very efficient, giving esters 6a-d. In order to demonstrate that such intermediates could be used to perform the desired ring closing aldol reaction, one of them (6a) was hydrolysed to acid 7 and converted to malonamide 8 by DCC coupling with oxazolidine 1.…”
mentioning
confidence: 99%
“…[3,4] Среди дигидропиразоло[1,5-a] пиримидинов обнаружен ряд эффективных модулято-ров Ca-и K-каналов. [5][6][7][8][9][10] Триазоло[1,5-a]пиримидины оказались перспективными антагонистами аденозин A 2A рецептора при лечении болезни Паркинсона. [11] Не-которые дигидротриазоло [1,5-a]пиримидины проявили антиконвульсантную на уровне Карбамазепина [12] и анти-пролиферативную [13] клеточную активность.…”
Section: Introductionunclassified
“…-дибензо [13,14:8,9] [1,4,7]триоксацикло-тетрадецино [11,10-e]азоло [1,5-a] Azolo [1,5-a]pyrimidines are considered to be purine analogues and they form one of the most promising groups of biologically active compounds [1][2][3][4][5][6][7][8][9][10][11][12][13][14][15][16] in medicinal chemistry. One of the strategies enhancing biochemical activity of azolo [1,5-a]pyrimidines is introduction of functional groups responsible for solubility and transport into their pharmacophore nucleus.…”
mentioning
confidence: 99%
“…[31][32][33][34][35][36][37][38][39] Discovered at first in 1893, 19,20 this reaction results in the condensation of three components: a urea, an aldehyde and a β-keto ester to form the 4-aryl-3,4-dihydropyrimidin-2(1H)-one (DHP) as shown in Scheme 1. …”
Section: Introductionmentioning
confidence: 99%